| Literature DB >> 25360616 |
Ludo Waltman1, Anthony F J van Raan1, Sue Smart2.
Abstract
We investigate the extent to which advances in the health and life sciences (HLS) are dependent on research in the engineering and physical sciences (EPS), particularly physics, chemistry, mathematics, and engineering. The analysis combines two different bibliometric approaches. The first approach to analyze the 'EPS-HLS interface' is based on term map visualizations of HLS research fields. We consider 16 clinical fields and five life science fields. On the basis of expert judgment, EPS research in these fields is studied by identifying EPS-related terms in the term maps. In the second approach, a large-scale citation-based network analysis is applied to publications from all fields of science. We work with about 22,000 clusters of publications, each representing a topic in the scientific literature. Citation relations are used to identify topics at the EPS-HLS interface. The two approaches complement each other. The advantages of working with textual data compensate for the limitations of working with citation relations and the other way around. An important advantage of working with textual data is in the in-depth qualitative insights it provides. Working with citation relations, on the other hand, yields many relevant quantitative statistics. We find that EPS research contributes to HLS developments mainly in the following five ways: new materials and their properties; chemical methods for analysis and molecular synthesis; imaging of parts of the body as well as of biomaterial surfaces; medical engineering mainly related to imaging, radiation therapy, signal processing technology, and other medical instrumentation; mathematical and statistical methods for data analysis. In our analysis, about 10% of all EPS and HLS publications are classified as being at the EPS-HLS interface. This percentage has remained more or less constant during the past decade.Entities:
Mesh:
Year: 2014 PMID: 25360616 PMCID: PMC4216103 DOI: 10.1371/journal.pone.0111530
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The 16 clinical fields included in the analysis.
| cardiac & cardiovascular systems | Ophthalmology |
| clinical neurology | Orthopedics |
| Dentistry | primary health care |
| dermatology | Psychiatry |
| hematology | public, environmental & occupational health |
| infectious diseases | respiratory system |
| obstetrics & gynecology | Surgery |
| Oncology | transplantation |
The five life science fields included in the analysis.
| cell & tissue engineering | materials science, biomaterials |
| chemistry, medicinal | neuroimaging |
| engineering, biomedical |
Figure 1Term map of the Clinical neurology field.
Colors indicate the average citation impact of the publications in which a term occurs.
Percentage of EPS-related terms per field.
| Field | % EPS terms | Field | % EPS terms |
| cardiac & cardiovas. systems | 4% | Psychiatry | 4% |
| clinical neurology | 5% | public, environ. & occup. health | 6% |
| Dentistry | 14% | respiratory system | 3% |
| dermatology | 6% | Surgery | 5% |
| Hematology | 3% | transplantation | 3% |
| infectious diseases | 3% | ||
| obstetrics & gynecology | 5% | cell & tissue engineering | 10% |
| Oncology | 10% | chemistry, medicinal | 24% |
| ophthalmology | 6% | engineering, biomedical | 31% |
| orthopedics | 9% | materials science, biomaterials | 41% |
| primary health care | 3% | neuroimaging | 15% |
The 16 clinical fields are listed first, followed by the five life science fields.
Figure 2Term map of the Clinical neurology field.
EPS-related terms are colored red. All other terms are colored green.
Figure 3Term map of the Clinical neurology field after zooming in into the clinical subfield.
Figure 4Term map of the Clinical neurology field after zooming in into the basic science subfield.
Figure 5Term map of the Dentistry field.
Figure 6Term map of the Dentistry field after zooming in into the clinical subfield.
Figure 7Term map of the Cardiac & cardiovascular systems field.
Figure 8Term map of the Cardiac & cardiovascular systems field after zooming in into the clinical subfield.
Figure 9Term map of the Biomedical engineering field.
Figure 10Term map of the Biomedical engineering field after zooming in into the imaging and radiation therapy subfield.
The 20 research topics at the EPS-HLS interface with the most significant growth in publication output.
| Research topic | No. ofpub. | Research theme |
| microenvironment; culture; perfusion; cellular response; chemotaxis | 1194 | Biological analysis |
| high content screening (hcs); segmentation; image data; rna interference (rnai) | 696 | Biological analysis |
| emission depletion; diffraction barrier; lateral resolution; point spread function(psf) | 696 | Biological analysis |
| tissue section; imaging mass spectrometry; matrix-assisted laser desorptionionization (maldi) imaging; spatial distribution; tissue surface | 383 | Biological analysis |
| carbon nanotube; nanomaterial; nanotechnology; multi-wall carbon nanotubes(mwcnt); titanium dioxide (tio2) | 1663 | Biomedical engineering and brain/neural |
| microbial fuel cell (mfc); anode; electricity | 1039 | Biomedical engineering and brain/neural |
| brain computer interface (bci); bci system; motor imagery; mental task | 812 | Biomedical engineering and brain/neural |
| critical assessment of prediction of interactions (capri); protein-proteindocking; interface residue; protein interface; hot spot | 743 | Genomics and proteomics |
| elastic network model (enm); normal mode analysis; adenylate kinase;allostery | 726 | Genomics and proteomics |
| ligand binding site; catalytic residue; pocket; functional site; unknownfunction | 685 | Genomics and proteomics |
| solid lipid nanoparticle (sln); nanostructured lipid carrier (nlc); lipid matrix | 629 | Materials for drug delivery and controlled release |
| feature selection; cancer classification; support vector machine (svm); classifier | 1011 | Medical statistics and informatics |
| reverse engineering; bayesian network; microarray data; gene expression data;regulatory relationship | 971 | Medical statistics and informatics |
| extracellular signal-regulated kinases (erk); mitogen-activated protein kinase(mapk); epidermal growth factor (egf) receptor; receptor | 722 | Medical statistics and informatics |
| gene ontology; go term; gene set enrichment analysis (gsea); gene set;enrichment analysis | 614 | Medical statistics and informatics |
| structure activity relationship (sar); hepatitis c virus nonstructural protein 5b(hcv ns5b) polymerase; boceprevir; compound | 822 | Medicinal chemistry |
| microtubule-associated protein 2 (mk2); map kinase inhibitor; fluorophenyl;alpha map kinase; birb | 648 | Medicinal chemistry |
| linoleic acid emulsion; superoxide anion radical scavenging; hydrogen peroxidescavenging; metal chelating activity; standard antioxidant | 350 | Natural products for pharmaceutical use |
| bacterium; photodynamic inactivation; staphylococcus aureus; biofilm;escherichia coli | 602 | Pharmaceutical and food analysis |
| melamine; cyanuric acid; milk; pet food; milk powder | 318 | Pharmaceutical and food analysis |
The number of publications relates to the period 2001–2010.
The 11 broad research themes at the EPS-HLS interface.
| Research theme | % of pub. |
| Biological analysis | 6.7% |
| Biomaterials | 7.6% |
| Biomedical engineering and brain/neural | 13.4% |
| Food chemistry | 6.0% |
| Genomics and proteomics | 8.4% |
| Materials for drug delivery and controlled release | 6.0% |
| Medical imaging and radiotherapy | 8.0% |
| Medical statistics and informatics | 7.3% |
| Medicinal chemistry | 13.2% |
| Natural products for pharmaceutical use | 12.4% |
| Pharmaceutical and food analysis | 11.0% |
For each research theme, the number of publications as a percentage of the total number of publications at the EPS-HLS interface is reported in the right column.
Figure 11The 11 broad research themes at the EPS-HLS interface and their location within the general structure of science.
Figure 12Yearly number of publications within each of the 11 broad research themes at the EPS-HLS interface.
Figure 13Term map of the Medical statistics and informatics research theme.
Colors indicate the average age of the publications in which a term occurs.
Contribution of the UK to the 11 research themes at the EPS-HLS interface.
| Research theme | % UKpublications | UK citationimpact score |
| Biological analysis | 5.6% | 0.96 |
| Biomaterials | 7.9% | 1.08 |
| Biomedical engineering and brain/neural | 9.3% | 1.12 |
| Food chemistry | 5.3% | 1.15 |
| Genomics and proteomics | 9.1% | 1.57 |
| Materials for drug delivery and controlled release | 5.6% | 1.12 |
| Medical imaging and radiotherapy | 7.2% | 1.35 |
| Medical statistics and informatics | 10.9% | 1.59 |
| Medicinal chemistry | 7.3% | 1.81 |
| Natural products for pharmaceutical use | 3.4% | 1.70 |
| Pharmaceutical and food analysis | 5.5% | 1.50 |